1. Home
  2. UNB vs ADVM Comparison

UNB vs ADVM Comparison

Compare UNB & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.73

Market Cap

107.6M

Sector

Finance

ML Signal

HOLD

Logo Adverum Biotechnologies Inc.

ADVM

Adverum Biotechnologies Inc.

HOLD

Current Price

$4.36

Market Cap

94.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
ADVM
Founded
1891
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.6M
94.6M
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
UNB
ADVM
Price
$23.73
$4.36
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.60
AVG Volume (30 Days)
11.2K
497.5K
Earning Date
01-14-2026
11-12-2025
Dividend Yield
6.07%
N/A
EPS Growth
27.30
N/A
EPS
2.47
N/A
Revenue
$52,533,000.00
N/A
Revenue This Year
N/A
$1,192.00
Revenue Next Year
N/A
N/A
P/E Ratio
$9.61
N/A
Revenue Growth
13.25
N/A
52 Week Low
$20.65
$1.78
52 Week High
$36.00
$6.12

Technical Indicators

Market Signals
Indicator
UNB
ADVM
Relative Strength Index (RSI) 56.53 58.20
Support Level $22.96 $4.15
Resistance Level $23.95 $4.23
Average True Range (ATR) 0.68 0.09
MACD 0.16 0.02
Stochastic Oscillator 62.40 95.22

Price Performance

Historical Comparison
UNB
ADVM

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: